Cargando…
Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis
INTRODUCTION: Hepatic steatosis is associated with cardiac systolic and diastolic dysfunction. Therefore, we evaluated metabolites and their potential cardiovascular effects in metabolic-dysfunction-associated fatty liver disease (MAFLD). MATERIALS AND METHODS: We conducted a cross-sectional study i...
Autores principales: | Ismaiel, Abdulrahman, Spinu, Mihail, Socaciu, Carmen, Budisan, Livia, Leucuta, Daniel-Corneliu, Popa, Stefan-Lucian, Chis, Bogdan Augustin, Berindan-Neagoe, Ioana, Olinic, Dan Mircea, Dumitrascu, Dan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764324/ https://www.ncbi.nlm.nih.gov/pubmed/35042855 http://dx.doi.org/10.1038/s41387-022-00182-7 |
Ejemplares similares
-
Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021) -
Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
por: Ismaiel, Abdulrahman, et al.
Publicado: (2022) -
MBOAT7 rs641738 variant in metabolic-dysfunction-associated fatty liver disease and cardiovascular risk
por: Ismaiel, Abdulrahman, et al.
Publicado: (2023) -
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021) -
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)